Globus Medical (GMED)
Official siteHEALTHCARE • MEDICAL DEVICES • NYSE
Market Cap: $9.57B
Last updated: Nov 17, 2026 at 11:06 AM ET
Globus Medical (GMED) P/E Ratio & Valuation History
Globus Medical (GMED) trades at 14.2x trailing earnings and 3.0x sales. Its P/E of 14.2x is below its 5-year median of 25.1x. Its forward P/E is 13.8x. The median P/E across 9 similar companies is 23.9x.
Current Multiples
Its forward P/E is below its trailing P/E, which implies earnings per share about 2.9% higher over the next year. Its free cash flow yield is 8.1%.
| Multiple | Value |
|---|---|
| P/E (trailing) | 14.2x |
| Forward P/E | 13.8x |
| Price to sales | 3.0x |
| Price to book | 2.0x |
| EV/EBITDA | 9.4x |
| Price to FCF | 12.3x |
| EV/FCF | 11.8x |
| PEG | 2.8 |
| FCF yield | 8.1% |
Historical Medians
Against its 10-year medians, its P/E is 48.7% below 27.7x, its P/S is 47.4% below 5.7x and its P/B is 41.2% below 3.4x.
| Multiple | Current | 5-year median | 10-year median |
|---|---|---|---|
| P/E | 14.2x | 25.1x | 27.7x |
| P/S | 3.0x | 4.3x | 5.7x |
| P/B | 2.0x | 2.6x | 3.4x |
Valuation History
Over the 10 year ends shown, its P/E ranged from 20.8x in 2016 to 45.6x in 2020.
| Year end | Price | P/E | P/S | P/B |
|---|---|---|---|---|
| 2025 | $87.31 | 21.8x | 4.0x | 2.6x |
| 2024 | $82.71 | 26.3x | 4.5x | 2.8x |
| 2023 | $53.29 | 22.9x | 4.0x | 1.9x |
| 2022 | $74.27 | 35.9x | 7.3x | 4.1x |
| 2021 | $72.20 | 35.4x | 7.6x | 4.3x |
| 2020 | $65.22 | 45.6x | 8.3x | 4.4x |
| 2019 | $58.88 | 34.8x | 7.4x | 4.2x |
| 2018 | $43.28 | 25.9x | 6.0x | 3.7x |
| 2017 | $41.10 | 31.6x | 6.3x | 4.2x |
| 2016 | $24.81 | 20.8x | 4.2x | 2.9x |
GNG Valuation
| GNG view | Undervalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About GMED
What is GMED's forward P/E ratio?
Globus Medical has a forward P/E ratio of 13.8x.
Is GMED stock overvalued?
GNG's valuation label for GMED is Undervalued. Its P/E of 14.2x compares with a median of 23.9x across 9 similar companies.
What is GMED's price to sales ratio?
Globus Medical has a price to sales ratio of 3.0x.
What is Globus Medical's average P/E ratio over 5 years?
Globus Medical's median P/E over the last 5 years is 25.1x, from 60 month-end values through Oct 2026.
What is GMED's PEG ratio?
Globus Medical has a PEG ratio of 2.8.
GMED pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors, Government Contracts